The export volume of insulin in dosage forms from the UK was 289.50 thousand kilograms in 2023. Forecasts indicate a steady growth from 295.67 thousand kilograms in 2024 to 327.78 thousand kilograms by 2028. The year-on-year growth shows an increase of 2.8% in 2025, 2.7% in 2026, 2.5% in 2027, and 2.4% in 2028. The compound annual growth rate (CAGR) over the forecast period from 2024 to 2028 is approximately 2.6%.
Future trends to watch for include potential impacts from regulatory changes, technological advancements in insulin delivery, and changes in global demand influenced by the prevalence of diabetes. Monitoring these factors will provide insights into future market dynamics and export opportunities.
